Pfizer Earnings & Forecasts

Pfizer (PFE) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Aug 4, 2026	$0.77	$0.68	13.2 %
Q1	May 5, 2026	$0.75	$0.72	4.17 %
Q4	Feb 3, 2026	$0.66	$0.56	17.9 %
Q3	Nov 4, 2025	$0.87	$0.65	33.9 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Aug 4, 2026	$15.03B	$14.43B	4.22 %
Q1	May 5, 2026	$14.45B	$13.81B	4.68 %
Q4	Feb 3, 2026	$17.56B	$16.87B	4.08 %
Q3	Nov 4, 2025	$16.65B	$16.55B	0.61 %

Pfizer Guidance

Pfizer (PFE)은 지난 8월 4, 2026에 fiscal year 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $2.8 - $3 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $2.97보다 높은 수치입니다. Pfizer는 또한 해당 기간의 매출을 $60.5B - $62.5B 범위로 전망했습니다.

이전 가이던스와 비교하여 Pfizer는 주당순이익(EPS) 전망치를 이전 범위인 유지됨에서 $2.8 - $3로 상향 조정했습니다. 매출 측면에서는 회사가 매출 전망치를 이전 범위인 유지됨에서 $59.5B - $62.5B로 상향 조정했습니다.

Pfizer은 23과 11월 1, 2022 사이에 8월 4, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.68	$0.72	$0.56	$0.65
Actual	$0.77	$0.75	$0.66	$0.87
Surprise	+13.2%	+4.17%	+17.9%	+33.9%
Revenue
Estimate	$14.43B	$13.81B	$16.87B	$16.55B
Actual	$15.03B	$14.45B	$17.56B	$16.65B
Surprise	+4.22%	+4.68%	+4.08%	+0.61%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.77	$0.71	$0.74	$0.66
Revenue
Consensus	$16.01B	$16.96B	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

Dow Jumps Over 900 Points As Crude Oil Falls: Investor Sentiment Improves Further, Fear Index Moves To ‘Greed’ Zone

Market sentiment improves, Dow Jones jumps 900 points to record high. Crude oil prices fall on potential deal to reopen Strait of Hormuz.

Avi Kapoor

Pfizer Says Monthly GLP-1 Candidate Could Rival Tirzepatide on Weight Loss

Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B. Get the key earnings takeaways.

Vandana Singh

Stock Market Today: S&P 500, Dow and Nasdaq Futures Gain as Scott Bessent Says Hormuz Deal Could Come Soon— Caterpiller, Palantir in Focus (UPDATED)

U.S. stock futures edged higher on Tuesday, with Dow, S&P 500 and Nasdaq 100 futures advancing after Wall Street's broad rally on Monday.

Eva Mathew

PRO
Pfizer Q2 Adj. EPS $0.77 Beats $0.69 Estimate, Sales $15.034B Beat $14.412B Estimate

Pfizer (NYSE:PFE) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.69 by 11.59 percent. This is a 1.28 percent decrease over earnings of $0.78 per share from the same period

Benzinga Newsdesk

PRO
Pfizer Affirms FY2026 Adj EPS Guidance of $2.80-$3.00 vs $2.95 Est; Raises FY2026 Sales Guidance from $59.500B-$62.500B to $60.500B-$62.500B vs $61.793B Est

Pfizer (NYSE:PFE) affirms FY2026 Adj EPS guidance from $2.80-$3.00 to $2.80-$3.00 vs $2.95 analyst estimate. Raises FY2026 sales outlook from $59.500 billion-$62.500 billion to $60.500 billion-$62.500 billion vs $61.793

Benzinga Newsdesk

Dow Closes at Record High, Nasdaq Surges 2%, but Fear & Greed Index Signals Investors Are Still Playing It Safe

Fear & Greed Index improves, Dow Jones hits record high, oil prices fall after Trump's Iran decision. CNH & Makemytrip stocks gain on earnings.

Avi Kapoor

Pfizer Inc